Orgenesis Price History

ORGSDelisted Stock  USD 1.22  0.31  20.26%   
If you're considering investing in Orgenesis OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Orgenesis stands at 1.22, as last reported on the 22nd of December, with the highest price reaching 1.55 and the lowest price hitting 1.10 during the day. Orgenesis maintains Sharpe Ratio (i.e., Efficiency) of -0.29, which implies the firm had a -0.29% return per unit of risk over the last 3 months. Orgenesis exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Orgenesis' Variance of 127.61, coefficient of variation of (587.98), and Risk Adjusted Performance of (0.13) to confirm the risk estimate we provide.
  
Orgenesis OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.289

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsORGS

Estimated Market Risk

 13.72
  actual daily
96
96% of assets are less volatile

Expected Return

 -3.96
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.29
  actual daily
0
Most of other assets perform better
Based on monthly moving average Orgenesis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orgenesis by adding Orgenesis to a well-diversified portfolio.

Orgenesis OTC Stock Price History Chart

There are several ways to analyze Orgenesis Stock price data. The simplest method is using a basic Orgenesis candlestick price chart, which shows Orgenesis price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Orgenesis OTC Stock Price History Data

The price series of Orgenesis for the period between Mon, Sep 23, 2024 and Sun, Dec 22, 2024 has a statistical range of 8.77 with a coefficient of variation of 32.36. The daily prices for the period are spread out with arithmetic mean of 5.86. The median price for the last 90 days is 6.08. The company underwent 1:10 stock split on 25th of September 2024. Orgenesis issued dividends to stockholders on 2017-11-16.
OpenHighLowCloseVolume
12/22/2024
 1.53  1.55  1.10  1.22 
10/22/2024 1.53  1.55  1.10  1.22  235,150 
10/21/2024 2.02  2.05  1.42  1.53  325,934 
10/18/2024 1.95  2.37  1.93  2.11  485,160 
10/17/2024 3.30  3.30  3.17  3.24  29,728 
10/16/2024 2.85  3.49  2.76  3.39  27,904 
10/15/2024 3.15  3.20  2.81  2.90  36,789 
10/14/2024 3.69  3.71  3.03  3.21  47,354 
10/11/2024 3.80  3.90  3.72  3.75  10,770 
10/10/2024 3.80  3.95  3.80  3.82  5,680 
10/09/2024 4.01  4.05  3.77  3.94  16,602 
10/08/2024 3.76  3.98  3.76  3.98  18,087 
10/07/2024 4.13  4.13  3.68  3.83  20,843 
10/04/2024 4.22  4.32  4.07  4.13  9,594 
10/03/2024 4.32  4.45  4.23  4.37  7,806 
10/02/2024 4.49  4.50  4.27  4.42  5,169 
10/01/2024 4.49  4.79  4.23  4.48  46,884 
09/30/2024 5.20  5.20  4.21  4.46  52,386 
09/27/2024 4.21  5.44  4.20  5.30  76,574 
09/26/2024 4.41  4.65  4.01  4.08  19,515 
09/25/2024 3.84  5.01  3.71  4.49  81,836 
09/24/2024 4.05  4.27  3.90  3.98  32,255 
09/23/2024 5.20  5.32  3.70  3.90  76,762 
09/20/2024 5.65  5.70  5.10  5.17  22,960 
09/19/2024 5.50  5.75  5.33  5.50  8,744 
09/18/2024 5.65  5.78  5.42  5.42  13,917 
09/17/2024 6.00  6.28  5.50  5.52  5,775 
09/16/2024 6.00  6.20  5.40  5.95  15,566 
09/13/2024 6.30  6.40  6.00  6.08  6,745 
09/12/2024 6.00  6.50  6.00  6.04  7,701 
09/11/2024 6.28  6.30  5.90  6.18  4,022 
09/10/2024 6.17  6.33  5.87  6.06  3,661 
09/09/2024 5.72  6.50  5.72  6.31  5,396 
09/06/2024 6.10  6.26  5.79  5.90  9,647 
09/05/2024 6.41  7.00  5.93  5.94  19,190 
09/04/2024 7.29  7.29  6.57  6.70  5,855 
09/03/2024 6.50  7.00  6.35  7.00  17,233 
08/30/2024 6.90  6.90  6.53  6.70  8,673 
08/29/2024 7.06  7.50  6.71  6.88  10,789 
08/28/2024 7.10  7.18  6.66  6.97  7,086 
08/27/2024 7.10  7.40  6.90  7.28  17,231 
08/26/2024 7.21  7.61  7.00  7.03  10,878 
08/23/2024 7.70  7.99  7.30  7.33  12,832 
08/22/2024 7.90  8.29  7.51  7.70  8,047 
08/21/2024 8.43  8.43  7.50  7.90  14,179 
08/20/2024 8.60  8.90  7.94  8.59  22,563 
08/19/2024 8.20  8.50  8.00  8.00  12,461 
08/16/2024 9.06  9.10  7.90  8.15  28,286 
08/15/2024 10.50  10.50  9.02  9.30  34,078 
08/14/2024 9.00  10.80  8.80  9.99  88,014 
08/13/2024 7.98  9.50  7.60  8.97  121,410 
08/12/2024 7.06  7.56  6.69  6.77  12,586 
08/09/2024 7.70  7.90  6.80  7.28  9,778 
08/08/2024 7.16  7.87  7.16  7.87  6,104 
08/07/2024 8.00  8.05  7.08  7.08  22,104 
08/06/2024 7.30  8.10  7.20  8.00  13,695 
08/05/2024 6.82  7.60  6.41  7.43  17,238 
08/02/2024 8.40  8.65  6.50  7.69  24,138 
08/01/2024 8.00  8.40  7.30  8.39  32,854 
07/31/2024 6.40  8.00  5.80  7.90  41,779 
07/30/2024 6.00  8.50  5.70  6.42  185,852 

About Orgenesis OTC Stock history

Orgenesis investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Orgenesis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Orgenesis will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Orgenesis stock prices may prove useful in developing a viable investing in Orgenesis
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland. Orgenesis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 151 people.

Orgenesis OTC Stock Technical Analysis

Orgenesis technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Orgenesis technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Orgenesis trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Orgenesis Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Orgenesis' price direction in advance. Along with the technical and fundamental analysis of Orgenesis OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Orgenesis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price.
Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Orgenesis OTC Stock

If you are still planning to invest in Orgenesis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orgenesis' history and understand the potential risks before investing.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stocks Directory
Find actively traded stocks across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.